Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cancer cells ’’commit suicide’’

30.09.2003


Catalysts which cause cancer cells to ’’commit suicide’’ have been developed in the laboratory by West Country scientists.



The research groups of Dr Claus Jacob, of Exeter University and Dr Nicholas Gutowski at the Royal Devon and Exeter Hospital, with support from the Peninsula Medical School, are investigating the anti-cancer effects of biocatalysts that mimic the activity of the human selenium enzyme, glutathione peroxidase. Their work opens up a very promising new direction for anti-cancer research, but both stress that any potential treatment for sufferers is still many years away.

Dr Jacob, of the University’’s School of Biological and Chemical Sciences, explained: ’’The catalysts work by initiating reactions inside the cancer cell that cause it to destroy itself. In effect, the cancer commits
suicide. One of the benefits of this approach is that the drugs target only the diseased cells.


The research opens up the possibility in the future of an entirely new way of treating cancer that has two advantages over conventional treatments:

1. The catalysts use the particular makeup of cancer cells for their activity and thus do not work in healthy cells. This means they are far more targeted than conventional drugs and could potentially avoid many of the unpleasant side effects associated with chemotherapy and radiotherapy.

2. Catalysts are not consumed during their activity but are recycled over and over again. This means that only minute quantities of biocatalyst are needed to kill cancer cells making them highly efficient.

Dr Jacob said: ’’Cancer therapy has long been based on highly toxic substances that randomly kill healthy and sick cells alike. This new approach might allow us to single out sick cells and kill them with a catalytic efficiency far superior to conventional radiation or chemotherapy. The experimental results obtained so far have been truly impressive but further evaluation and clinical trials are required to develop this.’’

The compounds have been developed and synthesised at the University’’s School of Biological and Chemical Sciences and tested in cancer cells at the Royal Devon and Exeter Hospital. The work has been partially funded by the Leverhulme Trust. An Exeter based company has already shown an interest in the compounds and the new method. The most active compound tested so far is a multifunctional catalyst that integrates a quinone with a chalcogen redox system in one chemically simple molecule.

Claus Jacob | alfa

More articles from Health and Medicine:

nachricht Deep stimulation improves cognitive control by augmenting brain rhythms
04.04.2019 | Picower Institute at MIT

nachricht Black nanoparticles slow the growth of tumors
04.04.2019 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

A stellar flare 10 times more powerful than anything seen on our sun has burst from an ultracool star almost the same size as Jupiter

  • Coolest and smallest star to produce a superflare found
  • Star is a tenth of the radius of our Sun
  • Researchers led by University of Warwick could only see...

Im Focus: Quantum simulation more stable than expected

A localization phenomenon boosts the accuracy of solving quantum many-body problems with quantum computers which are otherwise challenging for conventional computers. This brings such digital quantum simulation within reach on quantum devices available today.

Quantum computers promise to solve certain computational problems exponentially faster than any classical machine. “A particularly promising application is the...

Im Focus: Largest, fastest array of microscopic 'traffic cops' for optical communications

The technology could revolutionize how information travels through data centers and artificial intelligence networks

Engineers at the University of California, Berkeley have built a new photonic switch that can control the direction of light passing through optical fibers...

Im Focus: A long-distance relationship in femtoseconds

Physicists observe how electron-hole pairs drift apart at ultrafast speed, but still remain strongly bound.

Modern electronics relies on ultrafast charge motion on ever shorter length scales. Physicists from Regensburg and Gothenburg have now succeeded in resolving a...

Im Focus: Researchers 3D print metamaterials with novel optical properties

Engineers create novel optical devices, including a moth eye-inspired omnidirectional microwave antenna

A team of engineers at Tufts University has developed a series of 3D printed metamaterials with unique microwave or optical properties that go beyond what is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

Fraunhofer FHR at the IEEE Radar Conference 2019 in Boston, USA

09.04.2019 | Event News

 
Latest News

New automated biological-sample analysis systems to accelerate disease detection

18.04.2019 | Life Sciences

Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

18.04.2019 | Physics and Astronomy

New eDNA technology used to quickly assess coral reefs

18.04.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>